You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage II squamous cell carcinoma of the oropharynx

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head Neck Cancer, Oropharynx Cancer, Oropharyngeal Squamous Cell Carcinoma Trial in United States (Intensity modulated

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Intensity modulated radiotherapy (IMRT)/volumetric modulated arc therapy (VMAT) or Pencil beam proton therapy (PBPT)
  • Baltimore, Maryland
  • +5 more
Apr 26, 2022

Early-Stage Squamous Cell Carcinoma of the Oropharynx Trial in Australia, Canada (Radiotherapy, Transoral Robotic Surgery + Neck

Active, not recruiting
  • Early-Stage Squamous Cell Carcinoma of the Oropharynx
  • Radiotherapy
  • Transoral Robotic Surgery + Neck Dissection
  • Adelaide, Australia
  • +5 more
Aug 31, 2021

Head and Neck Squamous Cell Carcinoma, Cancer, Cancer of Head and Neck Trial in United States (Pembrolizumab, Radiation therapy,

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Tucson, Arizona
  • +6 more
Oct 7, 2021

Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity
  • +3 more
  • Eliminating RT to the elective neck
  • RT standard of care
  • Erlangen, Bavaria, Germany
    Universitätsklinikum Erlangen, Strahlenklinik
Sep 8, 2023

Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx Trial in Philadelphia

Active, not recruiting
  • Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx
  • Nelfinavir (Viracept®) 1250 mg
  • FMISO
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 30, 2021

Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell

Completed
Has Results
  • Stage IV Squamous Cell Carcinoma of the Hypopharynx
  • +3 more
  • Boston, Massachusetts
  • +1 more
Feb 11, 2021

Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7, Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage

Completed
  • Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7
  • +2 more
  • Durvalumab
  • Tremelimumab
  • Houston, Texas
    M D Anderson Cancer Center
Mar 16, 2021

Squamous Cell Carcinoma of the Oropharynx, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Carmel, Indianapolis (44

Recruiting
  • Squamous Cell Carcinoma of the Oropharynx
  • HPV Positive Oropharyngeal Squamous Cell Carcinoma
  • 44 doses of radiation
  • 54 doses of radiation
  • Carmel, Indiana
  • +1 more
Oct 5, 2022

Oropharynx Squamous Cell Carcinoma Trial in Ann Arbor (Nivolumab, Carboplatin, Paclitaxel)

Active, not recruiting
  • Oropharynx Squamous Cell Carcinoma
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Dec 20, 2022

Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell Trial in Amsterdam (radiotherapy, Olaparib)

Active, not recruiting
  • Laryngeal Cancer Stage II
  • +3 more
  • Amsterdam, Netherlands
    The Netherlands Cancer Institute
Sep 27, 2022

Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
  • (no location specified)
Mar 17, 2023

HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Orange (Intensity-Modulated Radiation Therapy (IMRT))

Recruiting
  • HPV Positive Oropharyngeal Squamous Cell Carcinoma
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Nov 4, 2022

Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
  • Black Raspberry
  • (no location specified)
Oct 16, 2023

Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and

Recruiting
  • Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • +4 more
  • Cemiplimab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 17, 2023

Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • no intervention
  • Wuhan, Hubei, China
    Renmin hosptial of Wuhan University
Jul 29, 2023

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic

Not yet recruiting
  • Head and Neck Cancer
  • +4 more
  • Experimental Observation
  • +3 more
  • Baltimore, Maryland
  • +5 more
Oct 16, 2023

Squamous Cell Carcinoma, Oropharynx Cancer, Head Neck Cancer Trial in Houston (SAR444245, Cemiplimab)

Not yet recruiting
  • Squamous Cell Carcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Houston (Control Group, TTI-101)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Houston, Texas
    M D Anderson Cancer Centerl
Apr 25, 2023

Neoadjuvent, PD-1 Inhibitor, Chemo Trial in Xi'an (Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin)

Recruiting
  • Neoadjuvent
  • +3 more
  • Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
  • Xi'an, Shaanxi, China
  • +2 more
Aug 17, 2023

Squamous Cell Carcinoma of the Oropharynx Trial in United States (Radiation Therapy)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oropharynx
  • Radiation Therapy
  • Miami, Florida
  • +3 more
Jul 22, 2023

Head and Neck Squamous Cell Carcinoma Trial in Dallas (Intensity modulated radiation therapy (IMRT))

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Intensity modulated radiation therapy (IMRT)
  • Dallas, Texas
    University of Texas Southwestern Medical Center - Dallas
Nov 18, 2022

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally

Recruiting
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +5 more
  • Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
  • Pembrolizumab
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Metastatic Penile Squamous Cell Carcinoma, Stage III Penile Cancer AJCC v8, Stage IV Penile Cancer AJCC v8 Trial in Phoenix,

Not yet recruiting
  • Metastatic Penile Squamous Cell Carcinoma
  • +3 more
  • Enfortumab Vedotin
  • Phoenix, Arizona
  • +2 more
Oct 23, 2023

Head Neck Cancer, Metastatic Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Winston-Salem (Pembrolizumab,

Recruiting
  • Head Neck Cancer
  • +5 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Health Sciences
Aug 8, 2022

Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

Active, not recruiting
Has Results
  • Squamous Cell Carcinoma of the Oropharynx
  • +7 more
  • Tampa, Florida
  • +2 more
Dec 30, 2022